WASHINGTON – Trying to get screened for the coronavirus before the holidays, Gia Ingenito stood in a long line at a free...
It’s shaping up to be a dark winter as Omicron surges in the US. But this year has also been one of...
An at-home treatment for COVID-19 that can prevent serious illness was authorized by the Food and Drug Administration on Wednesday, offering a...
Booster protection against symptomatic COVID-19 caused by Omicron lasts about 10 weeks, data shows. It may mean fourth doses in 2022 —...
Breast cancer that’s metastasized has spread to the bones, brain, lungs, or other parts of the body. Symptoms can depend on where...
U.S. health regulators cleared use of a Covid-19 pill from Pfizer Inc., the first drug that newly infected patients can now take...
Life expectancy in the United States decreased by nearly two years in 2020, mainly because of the pandemic, a new federal report...
Moderna is pausing a patent dispute with the federal government over its groundbreaking coronavirus vaccine, saying it is “grateful” to government scientists...
Astudy by Oregon researchers finds that people fully vaccinated against COVID-19 who have a breakthrough infection end up with what the authors call “super immunity...
The first large real-world study of how vaccines hold up against Omicron found that two shots of Pfizer Inc. and BioNTech SE’s...